In the mice who received tamoxifen treatment leading to CDA1 gene deletion, the diabetes-associated increases in the expression of these genes were significantly attenuated, showing no statistical difference when compared to their non-diabetic counterparts (Figure 4). The gene discussed is TSPYL2; the disease is diabetes mellitus.